Skip to main content

Table 2 Univariate linear regression analysis of factors correlated with the serum CRP concentration

From: Effect of erythropoietin-stimulating agent on uremic inflammation

Variable

Regression coefficient

p value

Age

0.136

<0.0001

Sex (F: 1, M: 2)

0.004

0.897

Diabetic nephropathy (no: 1, yes: 2)

−0.008

0.8087

BMI

0.052

0.1341

SBP

−0.087

0.0113

DBP

−0.068

0.0484

Duration of nephrologist care

−0.06

0.0775

CTR

0.134

0.0003

Albumin

−0.246

<0.0001

LDL-C

−0.084

0.0341

HDL-C

−0.153

<0.0001

Hemoglobin

−0.11

0.001

BUN

0.011

0.743

Creatinine

−0.102

0.0023

eGFR

0.122

0.0002

Uric acid

0.045

0.1861

Calcium

−0.118

0.0004

Phosphate

−0.021

0.5353

Intact-PTH

−0.007

0.8627

Platelets

0.061

0.068

WBC

0.14

<0.0001

ESA

−0.119

0.0005

ESA dose

−0.124

0.0007

ARB

−0.071

0.0361

ACE-I

−0.052

0.1282

ARB or ACE-I

−0.075

0.0261

ARB and ACE-I

−0.059

0.0841

CCB

−0.1

0.0032

other anti-HT

−0.065

0.0562

AST-120

−0.036

0.2943

Vitamin D

−0.058

0.0863

Iron agents

−0.072

0.1059

  1. BMI; body mass index, SBP; systolic blood pressure, DBP; diastolic blood pressure, CTR; Cardiothoracic ratio, WBC; white blood cell, Plt; platelets, LDL-C; low density lipoprotein cholesterol, HDL-C; high density lipoprotein cholesterol, BUN; blood urea nitrogen, eGFR; estimated glomerular filtration rate, PTH; parathyroid hormone, CRP; C-reactive protein, ESA; erythropoietin-stimulating agents, ARB; angiotensin-II receptor blockers, ACE-I; angiotensin-converting enzyme inhibitors, CCB; calcium channel blockers, anti-HT; antihypertensive.